Cite
HARVARD Citation
McInnes, I. et al. (2023). Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Lancet. 401 (10370), pp. 25-37. [Online].